Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DEAD-box helicase 43 pseudogene 1 (DDX43P1) is a pseudogene in the human genome. It does not encode a functional protein and has no established biological function or direct involvement as a therapeutic target. The closely related gene, DDX43 (also known as HAGE), is a functional helicase involved in RNA and DNA processing and is overexpressed in multiple cancers, serving as both a biomarker and a potential immunotherapy target[1][2][5]. Information directly relevant to DDX43P1 is lacking in biomedical literature, and it should not be confused with DDX43, which is the clinically relevant molecule in cancer research and therapy contexts. If you intended to refer to the protein-coding DDX43 (not the pseudogene DDX43P1), please clarify, as structured scientific information, including mechanisms, function, disease association, and drug interactions, pertains only to DDX43 and not to DDX43P1[1][2][5][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DEAD-box helicase 43 pseudogene 1 (DDX43P1).